The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression
Open accessAbstract
BACKGROUND: We compared transcranial direct-current stimulation (tDCS) with a selective serotonin-reuptake inhibitor for the treatment of depression. METHODS: In a single-center, double-blind, noninferiority trial involving adults with unipolar depression, we randomly assigned patients to receive tDCS plus oral placebo, sham tDCS plus escitalopram, or sham tDCS plus oral placebo. The tDCS was administered in 30-minute, 2-mA prefrontal stimulation sessions for 15 consecutive weekdays, followed by 7 weekly treatments. Escitalopram was given at a dose of 10 mg per day for 3 weeks and 20 mg per day thereafter. The primary outcome measure was the change in the 17-item Hamilton Depression Rating Scale (HDRS-17) score (range, 0 to 52, with higher scores indicating more depression). Noninferiority of tDCS versus escitalopram was defined by a lower boundary of the confidence interval for the difference in the decreased score that was at least 50% of the difference in the scores with placebo versus escitalopram. RESULTS: A total of 245 patients underwent randomization, with 91 being assigned to escitalopram, 94 to tDCS, and 60 to placebo. In the intention-to-treat analysis, the mean (±SD) decrease in the score from baseline was 11.3±6.5 points in the escitalopram group, 9.0±7.1 points in the tDCS group, and 5.8±7.9 points in the placebo group. The lower boundary of the confidence interval for the difference in the decrease for tDCS versus escitalopram (difference, -2.3 points; 95% confidence interval [CI], -4.3 to -0.4; P=0.69) was lower than the noninferiority margin of -2.75 (50% of placebo minus escitalopram), so noninferiority could not be claimed. Escitalopram and tDCS were both superior to placebo (difference vs. placebo, 5.5 points [95% CI, 3.1 to 7.8; P<0.001] and 3.2 points [95% CI, 0.7 to 5.5; P=0.01], respectively). Patients receiving tDCS had higher rates of skin redness, tinnitus, and nervousness than did those in the other two groups, and new-onset mania developed in 2 patients in the tDCS group. Patients receiving escitalopram had more frequent sleepiness and obstipation than did those in the other two groups. CONCLUSIONS: In a single-center trial, tDCS for the treatment of depression did not show noninferiority to escitalopram over a 10-week period and was associated with more adverse events. (Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo and others; ELECT-TDCS ClinicalTrials.gov number, NCT01894815 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Nitsche, M. A., & Paulus, W. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00633.x · Cited by 5,656
Murray, C. J. L., Barber, R. M., Foreman, K. J., Ozgoren, A. A., Abd-Allah, F., Abera, S. F., Aboyans, V., Abraham, J. P., Abubakar, I., Abu-Raddad, L. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61340-x · Cited by 1,964
Self-citationCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016
Bikson, M., Grossman, P., Thomas, C., Zannou, A. L., Jiang, J., Adnan, T., Mourdoukoutas, A. P., Kronberg, G., Truong, D., Boggio, P., et al. (2016) · Brain Stimulation · doi:10.1016/j.brs.2016.06.004 · Cited by 1,396
Self-citationBrunoni, A. R., Amadera, J., Berbel, B., Volz, M. S., Rizzerio, B. G., & Fregni, F. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001690 · Cited by 1,234
Self-citationMayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Amorim, P. (2000) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462000000300003 · Cited by 1,070
Brunoni, A. R., Valiengo, L., Baccaro, A., Zanão, T. A., de Oliveira, J. F., Goulart, A., Boggio, P. S., Lotufo, P. A., Benseñor, I. M., & Fregni, F. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.32 · Cited by 601
Self-citationBrunoni, A. R., Chaimani, A., Moffa, A. H., Razza, L. B., Gattaz, W. F., Daskalakis, Z. J., & Carvalho, A. F. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3644 · Cited by 520
Self-citationTranscranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial
Loo, C. K., Alonzo, A., Martin, D., Mitchell, P. B., Galvez, V., & Sachdev, P. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.097634 · Cited by 455
Brunoni, A. R., Moffa, A. H., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, E., Alonzo, A., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.164715 · Cited by 414
Self-citationSAFTEE: a technique for the systematic assessment of side effects in clinical trials.
Levine, J., & Schooler, N. (1986) · PubMed · Cited by 362
Validation of the State-Trait Distinction in Anxiety Research
Gaudry, E., Vagg, P., & Spielberger, C. D. (1975) · Multivariate Behavioral Research · doi:10.1207/s15327906mbr1003_6 · Cited by 260
Meron, D., Hedger, N., Garner, M., & Baldwin, D. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.012 · Cited by 220
Connolly, K. R., Helmer, A., Cristancho, M. A., Cristancho, P., & O’Reardon, J. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07413 · Cited by 185
Aparício, L. V. M., Guarienti, F., Razza, L. B., Carvalho, A. F., Fregni, F., & Brunoni, A. R. (2016) · Brain Stimulation · doi:10.1016/j.brs.2016.05.004 · Cited by 175
Self-citationSeibt, O., Brunoni, A. R., Huang, Y., & Bikson, M. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.01.401 · Cited by 169
Self-citationSomatic Treatments for Mood Disorders
Rosa, M. A., & Lisanby, S. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.225 · Cited by 155
Castillo-Saavedra, L., Gebodh, N., Bikson, M., Diaz‐Cruz, C., Brandao, R., Coutinho, L., Truong, D. Q., Datta, A., Shani‐Hershkovich, R., Weiss, M., et al. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.09.009 · Cited by 148
Self-citationAssessing non‐inferiority of a new treatment in a three‐arm clinical trial including a placebo
Pigeot, I., Schäfer, J., Röhmel, J., & Hauschke, D. (2003) · Statistics in Medicine · doi:10.1002/sim.1450 · Cited by 140
Valiengo, L. D. C. L., Goulart, A. C., de Oliveira, J. F., Benseñor, I. M., Lotufo, P. A., & Brunoni, A. R. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314075 · Cited by 114
Self-citationMinimum clinically important differences identified for commonly used depression rating scales
Masson, S. C., & Tejani, A. M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.01.010 · Cited by 88
Guarienti, F. A., Caumo, W., Shiozawa, P., Cordeiro, Q., Boggio, P. S., Benseñor, I. M., Lotufo, P. A., Bikson, M., & Brunoni, A. R. (2014) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12230 · Cited by 77
Self-citationBrunoni, A. R., Sampaio-Júnior, B., Moffa, A. H., Borrione, L., Nogueira, B. S., Aparicio, L. V. M., Veronezi, B. P., Moreno, M., Fernandes, R. A., Tavares, D. F., et al. (2015) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2014.00351712 · Cited by 61
Self-citationAmsterdam, J. D., & Justine Shults, A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181da5300 · Cited by 58
Nutt, D., Allgulander, C., Lecrubier, Y., Peters, T., & Wïttchen, H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091068 · Cited by 28
Cited by
Fregni, F., El-Hagrassy, M. M., Pacheco-Barrios, K., Carvalho, S., Leite, J., Simis, M., Brunelin, J., Nakamura-Palacios, E. M., Marangolo, P., Venkatasubramanian, G., et al. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa051 · Cited by 605
Self-citationBegemann, M. J., Brand, B. A., Ćurčić-Blake, B., Aleman, A., & Sommer, I. E. (2020) · Psychological Medicine · doi:10.1017/s0033291720003670 · Cited by 368
Chase, H. W., Boudewyn, M. A., Carter, C. S., & Phillips, M. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0499-9 · Cited by 286
“[70], finding a significant improvement in clinical symp-”
BackgroundFonteneau, C., Redoute, J., Haesebaert, F., Le Bars, D., Costes, N., Suaud-Chagny, M.-F., & Brunelin, J. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy093 · Cited by 198
Sackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
Metadata
- Authors
- Brunoni, A. R., Moffa, A. H., Sampaio-Junior, B., Borrione, L., Moreno, M. L., Fernandes, R. A., Veronezi, B. P., Nogueira, B. S., Aparicio, L. V. M., Razza, L. B., Chamorro, R., Tort, L. C., Fraguas, R., Lotufo, P. A., Gattaz, W. F., Fregni, F., & Benseñor, I. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-06-29
- Volume
- 376
- Issue
- 26
- Pages
- 2523-2533
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2732204853
- Cited by
- 408
- References
- 31
- FWCI
- 18.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.